In short
Overview
Every weight loss medicine reaches a point where weight stops falling. A plateau does not mean the medicine has stopped working.
Direct Answer
A Mounjaro weight loss plateau is the point at which the medicine reaches its maximal effect and weight stops falling. The plateau does not mean the medicine has stopped working; further loss needs additional steps, according to clinical guidance.
In SURMOUNT-1, weight loss on tirzepatide 15 mg averaged 20.9 percent at 72 weeks, about a fifth of body weight, with results sustained at 3 years.
Who This Applies To
- People on Mounjaro whose weight stopped falling.
- People not yet at the highest tolerated dose.
- People considering a switch to another medicine.
- People tempted to eat much less to restart loss.
Option Comparison / Decision Criteria
What explains a plateau on Mounjaro?
A plateau on Mounjaro has 4 common explanations.
| Explanation | Next step |
|---|---|
| Maximal effect reached at the goal dose | Maintenance at the same dose |
| Dose not yet at the highest tolerated level | Dose increase in 4-week steps |
| Lower energy use after weight loss | More activity, about 300 minutes a week |
| Muscle loss | Resistance training and 1 to 2 g of protein per kg |
Why an In-Person Physician Review Matters
What does the review decide?
The review decides whether to continue, raise the dose or change the medicine. The clinician reviews weight change, other health benefits and tolerability at an agreed interval, using the continuation criteria for the particular medicine.
Cost & Timeline
Bring dated weights and the dose history to the review. Reducing the dose after reaching the goal leads to regain: on 5 mg maintenance, weight loss fell back to 16.6 percent against 21.9 percent on the maximum tolerated dose after 52 weeks. The medicine: Mounjaro for weight loss. Keeping weight off: weight maintenance.
Frequently Asked Questions
No, a plateau means the medicine has reached its maximal effect; further loss needs additional steps.
Not automatically; a higher dose is considered when the highest tolerated dose has not been reached.
No, severe restriction worsens muscle loss; activity and protein help more.
When the agreed response is insufficient after an appropriate treatment period. Timing and continuation criteria depend on the particular medicine.
Evidence
Where this information comes from
Every figure on this page is taken from the sources below. All of them are free to read, so you can check them yourself.
- Mounjaro KwikPen: Summary of Product Characteristicselectronic medicines compendium (emc) · Dose, storage, contraception and pregnancy
- Overweight and obesity management (NG246)National Institute for Health and Care Excellence · Criteria and reviews
This page is general medical information and does not replace a personal consultation. Trial results are averages across large groups, not a prediction for any one person.